Incidence of salivary gland tumors among atomic bomb survivors, 1950- 1987. Evaluation of radiation-related risk

Radiation Research

Volumn 146, Issue 1, 1996, Pages 28-36

  Land, Charles E ^a   Saku, Takashi ^b,h   Hayashi, Yuzo ^c   Takahara, Osamu ^d   Matsuura, Hiroo ^e   Tokuoka, Shoji ⁱ   Tokunaga, Masayoshi ^f   Mabuchi, Kiyohiko ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

^c HIROSHIMA CITY ASA HOSPITAL   (Japan)

^d Nagasaki Red Cross Hospital   (Japan)

^e HIROSHIMA CITY HOSPITAL   (Japan)

^f Kagoshima City Hospital   (Japan)

^g RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^h NIIGATA UNIVERSITY   (Japan)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; WARTHIN TUMOR;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INCIDENCE; JAPAN; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RISK; SALIVARY GLAND NEOPLASMS; TIME FACTORS;

EID: 0030002168     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579392     Document Type: Article

References (33)

1. National Research Council, Committee on the Biological Effects of Ionizing Radiations, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V). National Academy Press, Washington, DC, 1990.
2. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, Annex A. Epidemiological Studies of Radiation Carcinogenesis. United Nations, New York, 1994.
3. Report of the National Institutes of Health Ad Hoc Working Group to Develop Radioepidemiological Tables. NIH Publication 85-2748, U.S. Government Printing Office, Washington, DC, 1985.
4. C. E. Land, Carcinogenic effect of radiation on the human digestive tract and other organs. In Radiation Carcinogenesis (A. C. Upton, R. E. Albert, F. Burns and R. E. Shore, Eds.), pp. 347-378. Elsevier/North Holland, New York, 1986.
5. E. L. Saenger, F. N. Silverman, T. D. Sterling and M. E. Turner, Neoplasia following therapeutic irradiation for benign conditions in childhood. Radiology 74, 889-904 (1960).
6. N. G. Hildreth, R. E. Shore, L. H. Hempelmann and M. Rosenstein, Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement. Radiat. Res. 102, 378-391 (1985).
7. M. L. Janower and O. S. Miettinen, Neoplasms after childhood irradiation of the thymus gland. J. Am. Med. Assoc. 215, 753-756 (1971).
8. A. B. Schneider, M. J. Favus, M. E. Stachura, M. J. Arnold and L. A. Frohman, Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann. Intern. Med. 87, 160-164 (1977).
9. E. Shore-Freedman, C. Abrahams, W. Recant and A. B. Schneider. Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation. Cancer 51, 2159-2163 (1983).
10. B. Modan, D. Baidatz, H. Mart, R. Steinitz and S. G. Levin, Radiation-induced head and neck tumors. Lancet 1, 277-279 (1974).
11. R. E. Shore, R. E. Albert and B. S. Pasternack, Follow-up study of patients treated by x-ray epilation for tinea capitis. Resurvey of post-treatment illness and mortality experience. Arch. Environ. Health 31, 17-24 (1976).
12. D. A. Hoffman, W. M. McConahey, J. F. Fraumeni and L. T. Kurland, Cancer incidence following treatment of hyperthyroidism. Int. J. Epidemiol. 11, 218-224 (1982).
13. L-E. Holm, P. Hall, K. Wiklund. G. Lundell, G. Berg, G. Bjelkengren, E. Cederquist, U-B. Ericsson, A. Hallquist, L-G. Larsson, M. Liberg, S. Lindberg, J. Tennvall, H. Wicklund and J. D. Boice, Jr., Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer Inst. 83, 1072-1077 (1991).
14. P. Hall, L-E. Holm, G. Bjelkengren, L-G. Larsson, S. Lindberg, J. Tennvall, H. Wicklund and J. D. Boice, Jr., Cancer risk in thyroid cancer patients. Br. J. Cancer 64, 159-163 (1991).
15. L. Teppo, E. Pukkala and E. Saxén, Multiple cancer - an epidemiological exercise in Finland. J. Natl. Cancer Inst. 75, 207-215 (1985).
16. S. Preston-Martin, D. C. Thomas, S. C. White and D. Cohen, Prior exposure to medical and dental X-rays related to tumors of the parotid gland. J. Natl. Cancer Inst. 80, 943-949 (1988).
17. J. L. Belsky, K. Tachikawa, R. W. Cihak and T. Yamamoto, Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. J. Am. Med. Assoc. 219, 864-868 (1972).
18. J. L. Belsky, N. Takeichi, T. Yamamoto, R. W. Cihak, F. Hirose, H. Ezaki, S. Inoue and W. J. Blot, Salivary gland neoplasms following atomic radiation: additional cases and reanalysis of combined data in a fixed population, 1957-1970. Cancer 35, 555-559 (1975).
19. N. Takeichi, F. Hirose and H. Yamamoto, Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan. I. Epidemiologic observations. Cancer 38, 2462-2468 (1976).
20. N. Takeichi, F. Hirose, H. Yamamoto, H. Ezaki and T. Fujikura, Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan. II. Pathologic study and supplementary epidemiologic observations. Cancer 52, 377-385 (1983).
21. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, S. Izumi and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors. 1958-1987. Radiat. Res. 137, S17-S67 (1994).
22. K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, D. L. Preston and D. E. Thompson, Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137, S1-S16 (1994).
23. M. Tokunaga, K. Mabuchi, H. Kato, L. Shimaoka and C. E. Land, Guidelines for the Conduct of Site-specific Cancer Incidence Studies among A-Bomb Survivors, Hiroshima and Nagasaki. Research Protocol 9-88, Radiation Effects Research Foundation, Hiroshima, 1988.
24. W. C. Roesch, Ed., U.S.-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki, Final Report, Vols. 1 and 2. Radiation Effects Research Foundation, Hiroshima, 1987.
25. D. L. Preston, J. H. Lubin and D. A. Pierce, Epicure User's Guide. HiroSoft International, Seattle, 1991.
26. R. Sposto and D. L. Preston, Correction for Catchment Area Nonresidency in Tumor-Registry-Based Cohort Studies. CR 1-92, Radiation Effects Research Foundation, Hiroshima, 1992.
27. Y. Shimizu, S. Kato and W. J. Schull, Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat. Res. 121, 120-141 (1990).
28. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat. Res. 123, 275-284 (1990).
29. M. Tokunaga, C. E. Land, T. Yamamoto, M. Asano, S. Tokuoka, H. Ezaki and I. Nishimori, Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat. Res. 112, 243-272 (1987).
30. ICRP, 1990 Recommendations of the International Commission on Radiological Protection. Publication 60, Annals of the ICRP 21, Nos. 1-3, Pergamon Press, New York, 1991.
31. M. Tokunaga, C. E. Land, S. Tokuoka, I. Nishimori, M. Soda and S. Akiba, Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1985. Radiat. Res. 138, 209-223 (1994).
32. T. Straume, S. D. Egbert, W. A. Woolson, R. C. Finkel, P. W. Kubic, H. E. Gove, P. Sharma and M. Hoshi, Neutron discrepancies in the DS86 Hiroshima dosimetry system. Health Phys. 63, 421-426 (1992).
33. T. Straume, L. J. Harris, A. A. Marchetti and S. D. Egbert, Neutrons confirmed in Nagasaki: Implications for Hiroshima. Radiat. Res. 138, 193-200 (1994).